AVPT
AvePoint, Inc.
AVPT's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over AVPT overall, supported by stronger valuation and stronger modeled upside.
AVPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Unavailable |
AVPT's revenue, profitability and cash flow are currently healthy. There isn't enough data to rate its balance sheet.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
AVPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 34x | $16.38 | — |
| Cheap | 48x | $15.89 | -3% |
| Current | 50x | $16.38 | — |
| Fair | 66x | $21.92 | +34% |
| Expensive | 7,357x | $2,428 | +14722% |
Historical ranges are pointers, not guarantees.
AVPT has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
AVPT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for AVPT, with profitability improving. However, they disagree widely on these estimates.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
AVPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.48 | +46% |
| Q3 2026 | $0.33 | +$0.33 |
| Q2 2026 | $0.31 | +$0.36 |
| Q1 2026 | $0.20 | +$0.33 |
| Q4 2025 | $0.15 | +$0.31 |
| Q3 2025 | $0.00 | +$0.05 |
| Q2 2025 | -$0.05 | +$0.03 |
| Q1 2025 | -$0.13 | -$0.05 |
| Q4 2024 | -$0.16 | -$0.04 |
AVPT has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over AVPT on earnings, with more consistent year-over-year improvement.
AVPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $131.1M | +19% |
| Q2 2026 | $124.5M | +22% |
| Q1 2026 | $117.2M | +26% |
| Q4 2025 | $114.7M | +29% |
| Q3 2025 | $109.7M | +24% |
| Q2 2025 | $102M | +31% |
| Q1 2025 | $93.1M | +25% |
| Q4 2024 | $89.2M | +20% |
AVPT's revenue has grown year over year every quarter since mid-2022: $131M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +1.3 points |
| Q2 2026 | 8.2% | +1.3 points |
| Q1 2026 | 11% | +7.3 points |
| Q4 2025 | 13% | +7.2 points |
| Q3 2025 | 7.4% | -1.2 points |
| Q2 2025 | 7% | +9.7 points |
| Q1 2025 | 3.5% | +7.8 points |
| Q4 2024 | 5.4% | +4.3 points |
AVPT's operating margin was 8.7% last quarter, up 1.3 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over AVPT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over AVPT on profitability, with a higher operating margin.
AVPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30M | -13% |
| Q2 2026 | $14.7M | -24% |
| Q1 2026 | $23M | +$24M |
| Q4 2025 | $29M | -9.5% |
| Q3 2025 | $34.3M | +11% |
| Q2 2025 | $19.3M | +22% |
| Q1 2025 | -$1M | -114% |
| Q4 2024 | $32M | +54% |
AVPT generated $97M in free cash flow over the past year, up 14% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over AVPT on cash flow, with more consistent year-over-year improvement.
AVPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +1.1M shares |
| 1 year | -4.7% | -10.9M shares |
| 3 years | +22% | +40.2M shares |
| 5 years | +534% | +187M shares |
AVPT has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30.9M |
| Q2 2026 | $50.5M |
| Q1 2026 | $59.8M |
| Q4 2025 | $22.4M |
| Q3 2025 | $8.4M |
| Q2 2025 | $7M |
| Q1 2025 | $11.9M |
| Q4 2024 | $11.3M |
AVPT spent $164M buying back its own shares over the past year, about four times what it spent the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
AVPT Net Leverage
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
AVPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.0 | Neutral |
| Stochastic | 83.1 | Overbought |
AVPT's weekly RSI is 66 (neutral) and its Stochastic is 83 (overbought).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
AVPT PE vs Technology Sector
| Metric | AVPT | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 28x | 78% above |
| PE % | 18 | 35 | 17 pts below |
AVPT is trading at 50x earnings, a 78% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over AVPT on valuation relative to its sector.
AVPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.3 | 6.9% above |
| 20 week MA | $13.9 | 18% above |
| 50 week MA | $12.3 | 33% above |
| 100 week MA | $14.3 | 14% above |
| 200 week MA | $11.3 | 45% above |
AVPT has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
AVPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.90 | $16.3 | +65% |
| 2021 | $16.3 | $6.50 | -60% |
| 2022 | $6.50 | $4.27 | -34% |
| 2023 | $4.27 | $8.21 | +92% |
| 2024 | $8.21 | $17.0 | +106% |
| 2025 | $17.0 | $13.8 | -19% |
| 2026 YTD | $13.8 | $16.4 | +19% |
AVPT's yearly returns have swung widely, from +106% in 2024 to −60% in 2021. It's up 19% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over AVPT on returns for 2026, with the stronger performance.